Peter Smith

Company: Remix Therapeutics

Job title: Co-Founder, President & Chief Executive Officer

Seminars:

Panel Discussion: Overcoming Key Challenges to Improve Drug Design & Discovery for Novel Approaches 3:30 pm

Navigating the current landscape of small molecules targeting RNA How can the unlimited potential to target RNA with small molecules be explored and exploited to develop novel approaches? What are the lessons from other modalities that can be leveraged to develop small molecules that target RNA? What needs to happen for this modality to become…Read more

day: Day 1 PM